Showing results (1971-1980 of 2,002) with videos related to

Sort By:
Pageof 201
Trials|August 17, 2022
Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherenceKaren L Margolis, A Lauren Crain, Beverly B Green, et al.
Journal of Medicinal Chemistry|November 7, 2014
Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitorsMark E Flanagan, Joseph A Abramite, Dennis P Anderson, et al.
Hypertension (Dallas, Tex. : 1979)|October 25, 2022
Comparing Pharmacist-Led Telehealth Care and Clinic-Based Care for Uncontrolled High Blood Pressure: The Hyperlink 3 Pragmatic Cluster-Randomized TrialKaren L Margolis, Anna R Bergdall, A Lauren Crain, et al.
Plos One|February 20, 2014
Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's diseaseGergely Tóth, Shyra J Gardai, Wagner Zago, et al.
Medrxiv : the Preprint Server for Health Sciences|June 3, 2024
Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypesMatthew Moll, Julian Hecker, John Platig, et al.
Scientific Reports|November 20, 2019
Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated DysfunctionsGergely Tóth, Thomas Neumann, Amandine Berthet, et al.
Ebiomedicine|November 7, 2024
Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes in the COPDGene and ECLIPSE cohort studiesMatthew Moll, Julian Hecker, John Platig, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2013
Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitorsSimeon Bowers, Anh P Truong, Michael Ye, et al.
Nature|May 21, 2010
A faint type of supernova from a white dwarf with a helium-rich companionH B Perets, A Gal-Yam, P A Mazzali, et al.
Bioorganic & Medicinal Chemistry Letters|November 30, 2010
Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegenerationGary D Probst, Simeon Bowers, Jennifer M Sealy, et al.
Pageof 201